Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit ...
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit ...
In a recent study published in the Frontiers of Cellular and Infection Microbiology, a group of researchers investigated the association ...
In 2019, more than 12,000 new cases of cervical cancer were diagnosed and upwards of 4,000 patients died in the ...
On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) ...
Study reveals English proficiency, income, and area-level unemployment are among the influential factors and highlights need for tailored interventions to ...
In celebration of International Women's Day 2024, we're honored to host Tim Simpson and Sarah Smith from Hologic, a forefront ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drive resistance to radiation ...
In a recent article published in BMC Medicine, researchers commented on a recently published study by Prem et al. that explored ...
A study conducted by LSU Health New Orleans' Schools of Public Health and Medicine faculty reports that diet contributes to ...
A recent University of Kentucky Markey Cancer Center study suggests a new radiopharmaceutical compound may be a viable treatment option ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net